Publications by authors named "Roger M Lane"

Claim this Profile
O
Onset of Alzheimer disease in apolipoprotein ɛ4 carriers is earlier in butyrylcholinesterase K variant carriers.
Roger M Lane, Taher Darreh-Shori, Candice Junge, Dan Li, Qingqing Yang

BMC Neurol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Tau-targeting antisense oligonucleotide MAPT in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial.
Catherine J Mummery, Anne Börjesson-Hanson, Daniel J Blackburn, Everard G B Vijverberg, Peter Paul De Deyn, Roger M Lane

Nat Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tau-targeting antisense oligonucleotide MAPT in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial.
Catherine J Mummery, Anne Börjesson-Hanson, Daniel J Blackburn, Everard G B Vijverberg, Peter Paul De Deyn, Roger M Lane

Nat Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Huntingtin Expression in Patients with Huntington's Disease.
Sarah J Tabrizi, Blair R Leavitt, G Bernhard Landwehrmeyer, Edward J Wild, Carsten Saft, Roger M Lane

N Engl J Med· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translating Antisense Technology into a Treatment for Huntington's Disease.
Roger M Lane, Anne Smith, Tiffany Baumann, Marc Gleichmann, Dan Norris

Methods Mol Biol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the beneficial and detrimental effects of donepezil and rivastigmine to improve their therapeutic value.
Roger M Lane, Taher Darreh-Shori

J Alzheimers Dis· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antidepressant drug development: Focus on triple monoamine reuptake inhibition.
Roger M Lane

J Psychopharmacol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restoration of positive mood states in major depression as a potential drug development target.
Roger M Lane

J Psychopharmacol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Butyrylcholinesterase genotype and gender influence Alzheimer's disease phenotype.
Roger M Lane, Yunsheng He

Alzheimers Dement· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of dementia rating scales in Parkinson's disease dementia.
Philip D Harvey, Steven H Ferris, Jeffrey L Cummings, Keith A Wesnes, Chuanchieh Hsu, Roger M Lane

Am J Alzheimers Dis Other Demen· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging hypotheses regarding the influences of butyrylcholinesterase-K variant, APOE epsilon 4, and hyperhomocysteinemia in neurodegenerative dementias.
Roger M Lane, Yunsheng He

Med Hypotheses· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients.
Paolo Barone, David J Burn, Teus van Laar, Chuanchieh Hsu, Werner Poewe, Roger M Lane

Mov Disord· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivastigmine in dementia associated with Parkinson's disease and Alzheimer's disease: similarities and differences.
Murat Emre, Jeffrey L Cummings, Roger M Lane

J Alzheimers Dis· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting acetylcholinesterase and butyrylcholinesterase in dementia.
Roger M Lane, Steven G Potkin, Albert Enz

Int J Neuropsychopharmacol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease.
Roger M Lane, Martin R Farlow

J Lipid Res· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acetylcholinesterase and its inhibition in Alzheimer disease.
Roger M Lane, Miia Kivipelto, Nigel H Greig

Clin Neuropharmacol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A placebo-controlled study of sertraline in the treatment of outpatients with seasonal affective disorder.
Adam Moscovitch, Carl A Blashko, John M Eagles, Guy Darcourt, Christopher Thompson, Roger M Lane

Psychopharmacology (Berl)· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder.
Joseph Zohar, Daniela Amital, Chanoch Miodownik, Moshe Kotler, Avi Bleich, Roger M Lane

J Clin Psychopharmacol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis